Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics

被引:566
|
作者
Jan, Rehmat [1 ]
Chaudhry, Gul-e-Saba [1 ]
机构
[1] Univ Terengganu Malaysia, Inst Marine Biotechnol, Terengganu 21030, Malaysia
关键词
Apoptosis; Apoptotic pathways; Cancer; c-FLIP; Caspases; Death receptors; Targeted drugs; PROGRAMMED CELL-DEATH; HISTONE DEACETYLASE INHIBITORS; AGONISTIC MONOCLONAL-ANTIBODY; TRAIL-INDUCED APOPTOSIS; ADVANCED BREAST-CANCER; BCL-2; FAMILY-MEMBERS; GAIN-OF-FUNCTION; PHASE-I TRIAL; DOWN-REGULATION; SMALL-MOLECULE;
D O I
10.15171/apb.2019.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results in the uncontrolled multiplication of cells leading to different diseases such as cancer. Currently, the development of apoptosis targeting anticancer drugs has gained much interest since cell death induced by apoptosis causes minimal inflammation. The understanding of complexities of apoptosis mechanism and how apoptosis is evolved by tumor cells to oppose cell death has focused research into the new strategies designed to induce apoptosis in cancer cells. This review focused on the underlying mechanism of apoptosis and the dysregulation of apoptosis modulators involved in the extrinsic and intrinsic apoptotic pathway, which include death receptors (DRs) proteins, cellular FLICE inhibitory proteins (c-FLIP), anti-apoptotic Bcl-2 proteins, inhibitors of apoptosis proteins (IAPs), tumor suppressor (p53) in cancer cells along with various current clinical approaches aimed to selectively induce apoptosis in cancer cells.
引用
收藏
页码:205 / 218
页数:14
相关论文
共 50 条
  • [21] Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer Therapeutics
    Shim, Jaehee
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 664A - 665A
  • [22] Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
    Rishi, Arun K.
    Zhang, Xinbo
    Wali, Anil
    CURRENT CANCER THERAPY REVIEWS, 2010, 6 (04) : 262 - 282
  • [23] Insights into molecular pathways for targeted therapeutics in acute leukaemia
    Stavropoulou, Vaia
    Brault, Laurent
    Schwaller, Juerg
    SWISS MEDICAL WEEKLY, 2010, 140 : 11 - 17
  • [24] The development of pro-apoptotic cancer therapeutics
    Ziedan, Noha I.
    Kadri, Hachemi
    Westwell, Andrew D.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 711 - 718
  • [25] Targeted cancer therapeutics: the heartbreak of success
    Douglas L Mann
    Nature Medicine, 2006, 12 : 881 - 882
  • [26] Molecularly targeted therapeutics for breast cancer
    Hussain, Syed A.
    Palmer, Daniel H.
    Spooner, David
    Rea, Daniel W.
    BIODRUGS, 2007, 21 (04) : 215 - 224
  • [27] Cancer heterogeneity: implications for targeted therapeutics
    R Fisher
    L Pusztai
    C Swanton
    British Journal of Cancer, 2013, 108 : 479 - 485
  • [28] Cancer heterogeneity: implications for targeted therapeutics
    Fisher, R.
    Pusztai, L.
    Swanton, C.
    BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 479 - 485
  • [29] Translating cancer research into targeted therapeutics
    J. S. de Bono
    Alan Ashworth
    Nature, 2010, 467 : 543 - 549
  • [30] The emergence of resistance to targeted cancer therapeutics
    Mellinghoff, IK
    Sawyers, CL
    PHARMACOGENOMICS, 2002, 3 (05) : 603 - 623